Lexington, MA-based e-Dialog has signed an agreement with Schering Laboratories to develop and manage an e-mail newsletter to help consumers cope with their allergies. Schering, Kenilworth, NJ, markets allergy medication Claritin. The newsletter will be e-mailed free upon request to Web site visitors who have completed Schering’s personal-allergy profiles at a health- and allergy-related Web site.
E-mail change of address service Return Path Inc., has formed a partnership with Lyris Technologies to integrate Return Path’s technology into Lyris’ e-mail permission marketing software. The integration project–targeted for completion by September 2001–will make Return Path capabilities available to Lyris’ 3,000 customers. Return Path is in New York and Lyris is in Berkeley, CA.
Network
